Zimmer Biomet Holdings, Inc. has agreed to acquire Monogram Technologies Inc. for $177 million in cash, with a potential additional payout of $12.37 per share if certain milestones are met by 2030. The deal will expand Zimmer Biomet’s robotics platform and offer fully autonomous surgical technology. The acquisition is expected to boost revenue growth in 2027, with earnings per share expected to be neutral in 2025-2027 and accretive in 2028. The transaction is projected to generate high-single digit return on invested capital by year five. The deal is subject to regulatory approvals and is expected to close later this year.

Read more at Nasdaq: Zimmer Biomet To Acquire Monogram Technologies In All Cash Deal Valued At About $168 Mln